Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Non-Current Assets |
---|---|
6/30/2025 | $ 148K |
3/31/2025 | $ 202K |
12/31/2024 | $ 4.39M |
9/30/2024 | $ 7.66M |
6/30/2024 | $ 11.82M |
3/31/2024 | $ 14.42M |
12/31/2023 | $ 12.37M |
9/30/2023 | $ 17.03M |
6/30/2023 | $ 18.02M |
3/31/2023 | $ 38.37M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 2.62K |
---|---|
min | $ 0 |
max | $ 1.86B |
average | $ 314.15M |
median | $ 90.27M |
std | $ 449.65M |